Blavatnik Len's Form 4 filing
Zura Bio Ltd (ZURA) · filed Mar 2, 2026
- Accession no.
- 0001193125-26-085900
- Filed
- Mar 2, 2026, 5:55 PM ET
- Trade date
- Feb 26, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $12.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blavatnik LenCIK 0001326628 | 10% Owner |
| Access Industries Holdings LLCCIK 0001391297 | 10% Owner |
| Access Industries Management, LLCCIK 0001508226 | 10% Owner |
| AI Biotechnology LLCCIK 0001942670 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Class A Ordinary Shares | PPurchaseAcquired | +2,000,000 | $6.25 | +$12,500,000 | 6,552,725 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.